You are here:

Experion Receives License to Extract and Produce Cannabis Oil

October 9, 2018 (Source) — Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce that its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), has received an amended license from Health Canada allowing for the production and possession of cannabis oil. The license permits Experion to purchase oils, create oils through the extraction process, conduct formulations, and destroy and store finished goods.

This licensing achievement is the key first step for Experion to participate in the cannabis derivatives market, which currently involves products such as basic oils and dosed gel capsules for medical purposes, and future recreational products, including edibles, distillates for vaporizer devices, infused beverages, and non-ingested products, such as topical creams and lotions.

Experion will start to produce cannabis oil within its current facility